Abstract:INTRODUCTION AND OBJECTIVE: Regulatory T cells (Tregs) play a major role in the development of an immunosuppressive tumor microenvironment. CCR8 has recently been identified as an important chemokine receptor on intratumoral Tregs and is known to be critical for CCR8+Treg-mediated immunosuppression. This study aimed to investigate the clinical significance and inherent molecular mechanisms of intratumoral CCR8+ Tregs in Muscle-invasive bladder cancer (MIBC). METHODS: 259 MIBC patients from two independent clinic centers were included in the study. 83 fresh MIBC tumor tissues were used to evaluate the proportion and function of immune cells via flow cytometry and ex vivo intervention experiments. 396 MIBC patients of TCGA were applied for bioinformatics analysis. RESULTS: We found that the CCR8 expression by intratumoral Tregs maintained the stability and potentiated their suppressive function by upregulating the expression of transcript factors Foxo1 and c-Maf. High level of CCR8+ Tregs is associated with immune tolerance and predicts poor survival and inferior therapeutic responsiveness to chemotherapy. Moreover, we revealed that CCR8 blockade using neutralizing antibody destabilized intratumoral Tregs into a fragile phenotype, reactivated the antitumor immunity and augmented the therapeutic benefits of the anti-PD-1 antibody in MIBC. CONCLUSIONS: Our study presents the mechanism of CCR8 in maintaining the stability of intratumoral Tregs in MIBC and indicates that therapeutic targeting of CCR8 could provide a more specific modulation of Tregs and augment immunotherapy in patients with MIBC.Source of Funding: This study was funded by grants from National Natural Science Foundation of China (81570607, 81671628, 31770851, 81702496, 81702497, 81702805, 81772696, 81871306, 81872082, 81902556, 81902563, 81902898, 81974393), Three-year action plan for promoting clinical skills and clinical innovation in municipal hospitals of Shanghai Shenkang (16CR2003A), National Natural Science Foundation for Young Scholars of China (81902566), Shanghai Jiaotong University Medical-Engineering Cross Research Fund (YG2019QNA53), National Key R&D Program of China (2017YFC0114303), Shanghai Municipal Natural Science Foundation (16ZR1406500, 17ZR1405100, 19ZR1431800), Guide Project of Science and Technology Commission of Shanghai Municipality (17411963100), Shanghai Sailing Program (18YF1404500, 19YF1407900, 19YF1427200), Shanghai Municipal Commission of Health and Family Planning Program (20174Y0042, 201840168, 20184Y0151), Fudan University Shanghai Cancer Center for Outstanding Youth Scholars Foundation (YJYQ201802) and Shanghai Cancer Research Charity Center. All these study sponsors have no roles in the study design, in the collection, analysis and interpretation of data.

In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications

CCR8 Blockade Primes Anti-Tumor Immunity Through Intratumoral Regulatory T Cells Destabilization in Muscle-Invasive Bladder Cancer

Targeting tumor-infiltrating CCR8+ regulatory T cells induces antitumor immunity through functional restoration of CD4+ Tconvs and CD8+ T cells in colorectal cancer

CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory

CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation

Mp55-02 ccr8 blockade primes anti-tumor immunity through intratumoral regulatory t cells destabilization in muscle-invasive bladder cancer

CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function

Regulatory T‐cells activated in metastatic draining lymph nodes possibly suppress cancer immunity in cancer tissues of head and neck squamous cell cancer

Regulatory T, B cells and inflammation: Do they play an important role in lung cancer?

Blockade of TNF-α/TNFR2 signalling suppresses colorectal cancer and enhances the efficacy of anti-PD1 immunotherapy by decreasing CCR8+ T regulatory cells

Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer

In situ analysis of FOXP3+ regulatory T cells and myeloid dendritic cells in human colorectal cancer tissue and tumor-draining lymph node.

Insight into the significance of CD8+ tumor-infiltrating lymphocytes in squamous cell lung cancer

Enrichment of CCR6+Foxp3+ Regulatory T Cells in the Tumor Mass Correlates with Impaired CD8+ T Cell Function and Poor Prognosis of Breast Cancer.

Research progress of CCR8 in tumor immunotherapy

In Situ Prior Proliferation of CD4+ CCR6+ Regulatory T Cells Facilitated by TGF-β Secreting DCs is Crucial for Their Enrichment and Suppression in Tumor Immunity.

Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody

Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future Perspectives

Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients

CD8+ T Cells Form the Predominant Subset of NKG2A+ Cells in Human Lung Cancer

Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues